Our current study has hinted that EBI3 silencing could suppress the proliferation, migration and invasion of melanoma cells, concurrent with the diminished expression of CDH2 and BCL2 yet the upregulated expression of CDH1 and BAX. This evidence concerns the gene BCL2 and melanoma.